Lowey Dannenberg, P.C. is Investigating Capricor Therapeutics, Inc. (NASDAQ: CAPR) for Potential Violations of the Federal Securities Laws
Globe Newswire•04/08/2026•15:38 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.